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Abstract
Recently, the presence of 2V,5V-linked oligoadenylates and a high 2V,5V-oligoadenylate synthetase activity were discovered in a lower
invertebrate, the marine sponge Geodia cydonium. It has been demonstrated that mammalian 2–5A synthetase isozymes require a dsRNA
cofactor for their enzymatic activity. Our results show that, unlike mammalian 2–5A synthetases, the 2–5A synthetase from the sponge acts
in a dsRNA-independent manner in vitro. A prolonged incubation of the G. cydonium extract with a high concentration of a micrococcal
nuclease had no effect on the activity of the 2–5A synthetase. At the same time, the micrococcal nuclease was effective within 30 min in
degrading dsRNA needed for the enzymatic activity in IFN-induced PC12 cells. These results indicate that the 2–5A synthetase from G.
cydonium may be active per se or is activated by some other mechanism. The sponge enzyme is capable of synthesizing a series of 2–5A
oligomers ranging from dimers to octamers. The accumulation of a dimer in the predominant proportion during the first stage of the reaction
was observed, followed by a gradual increase in longer oligoadenylates. By its product profile and kinetics of formation, the sponge 2–5A
synthetase behaves like a specific isoform of enzymes of the 2–5A synthetase family. D 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
Higher vertebrates have evolved a number of defense
mechanisms to control viral infection. One of the most
extensively characterized mechanisms among them is an
interferon (IFN)-stimulated 2V,5V-linked oligoadenylate (2–
5A) pathway or a 2–5A system (reviewed in Refs. [1,2]).
By now, it has been demonstrated that the 2–5A system
functions as an antiviral pathway in vivo in animals [3].
Other possible functions such as growth control and the
control of apoptosis have also been suggested for this
enzyme system [4–7].
The key enzyme of the 2–5A pathway, (2V–5V) oligoa-
denylate synthetase (2–5A synthetase: EC 2.7.7.-) converts
cellular ATP to a series of short 2V,5V-linked oligoadenylates
(2–5A) with a general formula pppA(2Vp5VA)n, nz 1 [8]. In
human cells, three types of IFN-induced 2–5A synthetases
have been cloned, expressed and characterized correspond-
ing to small (p40, p46), medium (p69, p71) and large (p100)
isoforms [9]. The enzymatic activity of all these isoforms
requires a cofactor, a double-stranded RNA [9,10]. Their
enzymatic product, 2–5A, functions as an allosteric activa-
tor of a latent endoribonuclease (RNase L), which degrades
a single-stranded viral or cellular RNA [11,12].
2–5A synthetases of the sizes similar to those of the
synthetases found in humans have been identified in other
vertebrates (mouse, rat, pig, woodchuck, chicken) [13,14].
The 2–5A synthetase family also comprises homologous
proteins without the 2–5A synthesizing activity; these
members are called 2–5A synthetase-like proteins [15,16].
Contrary to the wide occurrence of the 2–5A synthetase in
vertebrates, this enzyme has not been found in lower
organisms such as bacteria and C. elegans [13,14,17].
In our earlier study, we discovered the presence of 2V,5V-
linked oligoadenylates and a high 2–5A synthetase activity
in a lower invertebrate, the marine sponge Geodia cydonium
[18]. The 2V,5V phosphodiester bond in the oligoadenylates
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was verified by the NMR analysis and the oligonucleotide
composition was determined by using the MALDI-MS
method [19]. We also succeeded in cloning the putative
2–5A synthetase from the marine sponge G. cydonium [20].
Although we have demonstrated the presence of the 2–
5A synthesizing activity in the sponge G. cydonium, the role
of the 2–5A synthesis in sponges has not been defined.
Sponges are known to live in symbiosis with certain bacteria
and unicellular eukaryotic organisms (reviewed in Ref.
[21]). Besides, as sponges are filter-feeding metazoa, they
are exposed to a huge amount of organic matter via the
extraction of edible material from the water [22]. Accord-
ingly, sponges have developed an effective chemical
defense system as well as humoral and cellular defense
mechanisms against toxic substances or organisms [23,24].
Whether the 2–5A synthetase in sponges is, similar to
vertebrates, involved in defense reactions against viruses
or microorganisms, is not known at present. It has been
reported that the 2–5A synthetase activity in the marine
sponge G. cydonium can be modulated by some environ-
mental stressors [25]. However, in order to understand the
function of the 2–5A synthesis in sponges, the factors
needed for the activation of the 2–5A synthetase as well
as catalytic properties of the enzyme will have to be
established.
While searching for the possibilities of a biochemical
characterization of the sponge enzyme, we found that
contrary to mammalian enzymes, the sponge 2–5A synthe-
tase, which was immobilized to Hybond N + membrane, did
not need poly(I)poly(C) as a dsRNA cofactor for its
enzymatic activity in vitro. The nuclease treatments of the
G. cydonium extracts that were effective in degrading the
dsRNA needed for the enzymatic activity in mammalian
cells did not influence the observed 2–5A synthetase
activity.
The enzyme from G. cydonium is capable of synthesizing
2–5A oligomers from dimers to octamers with the accumu-
lation of the dimer in a predominant proportion during the
first stage of the reaction. The enzymatic studies demon-
strate that in the absence of dsRNA, the sponge 2–5A
synthetase behaves like a specific isoform of enzymes of the
2–5A synthetase family.
2. Materials and methods
2.1. Materials
Adenosine 5V-triphosphate was purchased from Reanal
(Budapest, Hungary). [14C]ATP (50–60 mCi/mmol) was
purchased from Amersham and purified by HPLC. Poly-
ethyleneimine (PEI)-cellulose TLC-Ready-Plates were from
Schleicher and Schuell (Germany). The membranes Hybond
N + , Hybond N, Hybond C and PVDF were from Amersham
International PLC (Buckinghamshire, UK). Poly(I)poly(C),
creatine kinase (EC 2.7.3.2) and phosphocreatine were
obtained from Boehringer Mannheim (Germany). DNA
(Type I, highly polymerized, from calf thymus) and micro-
coccal nuclease (EC 3.1.31.1; 107 U/mg protein) were
obtained from Sigma Chemical Co. (St. Louis, MO, USA).
The shrimp alkaline phosphatase (SAP) was from USB
Corporation (Cleveland, OH, USA).
2.2. Sponge
Specimens of the marine sponge G. cydonium (Porifera,
Demospongiae, Geodiidae) were collected near Rovinj
(Croatia) at depths between 15 and 35 m, cut to pieces
and immediately frozen in liquid nitrogen. The frozen pieces
were stored at  70 jC.
2.3. Cell extracts
The frozen sponge tissue was mechanically broken in
liquid nitrogen and during homogenization, a lysis buffer
was added (1.5–2 v/w), consisting of 10 mM HEPES, pH
7.6, 90 mM KCl, 1 mM Mg-acetate, 0.5% NP-40 and 2 mM
2-mercaptoethanol. The supernatant obtained after centrifu-
gation (10,000 g; 10 min; 4 jC) was immediately frozen
in liquid nitrogen and stored at  70 jC (crude extract).
The extracts of g-IFN-induced PC12 cells were prepared
as described earlier [26] and stored at  70 jC.
Protein concentration in cell extracts was measured by a
modified Bradford method [27].
2.4. 2–5A synthetase activity assay
The 2–5A synthetase activity in the extracts was deter-
mined after binding the enzyme to the poly(I)poly(C)mem-
brane as described earlier [18], or simply after binding the
enzyme to the positively charged nylon membrane Hybond
N + . The crude sponge extract (20 Al, 200–300 Ag of total
protein) or IFN-induced PC12 cell extract (20 Al, 200–300
Ag of total protein) was added to a 0.16 cm2 membrane
piece. The binding was performed in microtiter plate wells
at room temperature by gently shaking for 30 min. The
membrane was washed for 4 5 min with 200 Al of the
reaction buffer (without ATP) and shortly dried on the filter
paper. Then, 50 Al (10 Al for radioactive assays) of the
reaction mixture (30 mM Tris–HCl, pH 8.0, 100 mM KCl,
5 mM MgCl2, containing 1 mM ATP as a substrate and
20,000 cpm of [14C]ATP-omitted in nonradioactive assays)
was applied to each piece of the membrane.
Using different batches of crude extracts, we obtained
membranes with different 2–5A synthesizing activities
(approximately 10–75% of ATP converted into its products
per hour). Thus, each series of experiments was performed
with the same batch of the extract.
In activity assays ‘‘in solution,’’ we incubated the reac-
tion mixture which contained 2 Al of the sponge extract (30
Ag of the total protein) in a final volume of 50 Al at 37 jC in
the presence or absence of 100 Ag/ml of poly (I)poly(C).
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Contrary to the crude G. cydonium extracts, the PC12
cell extracts contain a remarkable ATPase activity that
competes with the 2–5A synthetase for the substrate.
Therefore, to avoid the degradation of ATP through the
phosphatase activity, the ATP regenerating system (0.5 mg/
ml creatine kinase, 30 mM phosphocreatine) was added to
the reaction mixture in these experiments.
After 0.5–4 h, depending on the rate of conversion of
ATP to its products, the reaction was terminated. For that,
the reaction mixture was heated for 5 min at 95 jC and the
products were analysed in their triphosphorylated form.
Alternatively, to analyse the products in their ‘‘core’’ form
the reaction mixture was treated with the SAP (0.04 U/Al,
1–1.5 h at 37 jC) to remove the 5V phosphate groups
followed by the inactivation of the enzyme for 15 min at
65 jC.
2.5. TLC separation of the products
In radioactive assays, the reaction products were sepa-
rated by TLC on PEI-cellulose [18,25]. As a mobile phase
0.4 M Tris–HCl (pH 8.6) containing 30 mM MgCl2 were
used. The dried TLC plates were exposed to a CS-imaging
screen and scanned by using the Bio-Rad GS-525 Molecular
Imager System. The amounts of ATP and 2–5A oligomers
were quantified by the relative intensities of the correspond-
ing spot areas on the autoradiograms.
2.6. HPLC analysis of the reaction products
The reaction products were analysed on the HPLC
apparatus (Waters) equipped with a C18 reverse-phase
column (Supelcosilk LC-18, 300 4.6 mm, 5 Am). The
2V–5V-linked triphosphorylated oligoadenylates were sepa-
rated in the system which consisted of solvent A (50 mM
NH4H2PO4, pH 7.0) and solvent B (MeOH/H2O, 1:1), by
applying a 1–60% gradient of solvent B in solvent A for 30
min. The absorbance was measured at 254 nm. The dephos-
phorylated oligoadenylates (the ‘‘core’’ form of oligomers)
were separated in the system which consisted of solvent A
(0.1 M triethylammoniumacetate (TEAA), pH 7.0) and
solvent B (40% acetonitrile/0.1 M TEAA, pH 7.0), by
applying a 10–30% gradient of solvent B in solvent A for
30 min. The absorbance was measured at 265 nm. The
retention times of ATP, adenosine and 2–5A oligoadeny-
lates, in either their triphosphorylated or ‘‘core’’ form were
estimated by comparing them with those of authentic com-
pounds and individual chemically synthesized 2–5A oli-
goadenylates. The structure of 2V,5V-linked oligoadenylates
has been previously verified by enzymatic (ribonuclease U2
and alkaline phosphatase) treatments and by a biological
assay in rabbit reticulocyte lysates [18] and also directly by
NMR analysis and the MALDI-MS method [19]. The
quantification of the products was performed by measuring
the relative peak areas (Millenium32 version 3.05 software,
Waters Corporation). In calculations, the molar absorption
coefficients of 1.54 104, 2.58 104, 3.60 104,
4.16 104, and 5.0 104 were used for ATP, 2V,5V-linked
A2, A3, A4, and A5, respectively [28].
2.7. Nuclease treatments
Micrococcal nuclease treatments were performed in
‘‘crude extracts’’ as well as on the membrane-bound mate-
rial from the sponge extract. As a control, the IFN-induced
PC12 cell extract was used as a dsRNA-dependent mamma-
lian model system of the 2–5A formation.
2.7.1. Treatment of the sponge material
For the hydrolysis of nucleic acids in crude extracts, 95
Al of the crude extract were incubated at 37 jC in the
presence of 10 mM Tris–HCl buffer, pH 8.6, 10 mM CaCl2
and 0.05 U/Al of the micrococcal nuclease (final volume 100
Al) for various periods of time (0 to 22 h). Then the extract
was used to determine the Hybond N + -bound 2–5A
synthetase activity or the 2–5A synthetase activity ‘‘in
solution’’ as described above.
To study the effect of the nuclease on the Hybond N + -
bound material, the membrane was subsequently washed
and incubated with 100 Al of 100 mM glycine buffer (pH
8.6) containing 10 mM CaCl2, in the presence or absence of
0.05 U/Al of the micrococcal nuclease at room temperature
for 30 min. After the washing step, the 2–5A synthetase
activity was determined.
To follow the nucleic acid (endogenous or added) deg-
radation in the extracts, the time-dependent increase in the
absorbance at 260 nm was monitored. For that, the extracts
were supplemented with 10 mM Tris–HCl, pH 8.6 and 10
mM CaCl2 in either the presence or absence of 0.05 U/Al of
the micrococcal nuclease.
2.7.2. Experiments with PC12 cells
To study the effect of the nuclease on dsRNA, the reaction
mixture, which contained 1 mM ATP, 10 Ag/ml or 100 Ag/ml
of poly(I)poly(C) and 2.5 mM CaCl2 in the reaction buffer,
pH 8.0, was incubated for 30 min at 30 jC in the presence or
absence of 0.05 U/Al of the micrococcal nuclease. The
preincubated mixture was added to the Hybond N + -bound
enzyme from the PC12 cell extracts in order to carry out the
reaction. Alternatively, the poly(I)poly(C)-membrane was
treated with the micrococcal nuclease as described and, after
washing the membrane, the enzyme from the PC12 cell
extract was bound to it and the 2–5A synthetase activity
measured.
In another series of experiments, the effect of the
nuclease was studied after the formation of the 2–5A
synthetase–dsRNA complex. The enzyme from PC12 cells
was bound to the poly(I)poly(C)-membrane, the membrane
was washed and treated with the micrococcal nuclease in the
glycine buffer as described above. After washing the mem-
brane, the 2–5A synthetase activity assay was performed.
Alternatively, the enzyme from PC12 cells was bound to the
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Hybond N + -membrane followed by the sequential binding
of the poly(I)poly(C), micrococcal nuclease treatment and
the addition of the reaction mixture. Between all the steps,
the membrane was washed. The reaction products were
subjected to HPLC analysis.
3. Results
3.1. 2–5A synthetase activity test with sponge extracts using
poly(I)poly(C)membrane-bound and Hybond N+-bound
enzyme assays
The poly(I)poly(C)membrane-bound enzyme activity
test has been typically used to study the 2–5A synthetase
activity in mammalian cell extracts [29]. As shown in our
earlier reports [18,19], the enzyme from G. cydonium was
also capable of synthesizing 2V,5V-linked oligoadenylates
when immobilized to the poly(I)poly(C)membrane. As a
control of the binding specificity, we used a positively
charged nylon membrane (Hybond N + ) instead of the
poly(I)poly(C)membrane which was prepared on the basis
of Hybond N + . Surprisingly, the use of the Hybond N +
membrane also enabled the synthesis of 2–5A oligomers.
Analysis of the reaction products showed no difference
between the profiles of the products (Fig. 1A) and the yields
of 2–5A oligomers (Fig. 1B), regardless of whether the
poly(I)poly(C)membrane or Hybond N + membrane was
used for the immobilization of the enzyme. The use of other
membranes (Hybond C, Hybond N, PVDF) also gave
positive results, suggesting that the protein binding was
nonspecific.
The crude extracts of G. cydonium may contain possible
dsRNA activators of the 2–5A synthetase which bind to the
Hybond N + membrane together with the enzyme and
activate it. Therefore, in order to carry out the hydrolysis
of nucleic acids, we undertook the treatment of the extracts
with the micrococcal nuclease.
3.2. The nuclease treatment of sponge extracts
To follow the degradation of nucleic acids in the extracts,
the micrococcal nuclease was added to the extract and an
increase in the absorbance was registered at 260 nm. A
sharp rise in A260 was observed during the first 30 min of
incubation, followed by a subsequent slower increase (not
shown). In the presence of the micrococcal nuclease the
total increase in the absorbance was twice higher than in the
absence of the nuclease, the latter, in its turn, was evidently
caused by endogenous nucleases. These results confirm the
occurrence of hydrolysis of nucleic acids in the extracts. To
ensure complete hydrolysis of endogenous nucleic acids, the
crude extracts of G. cydonium were incubated with the
micrococcal nuclease for prolonged periods of time (up to
overnight) followed by the 2–5A synthetase activity assay.
The results presented in Table 1 demonstrate that the
pretreatment of the extract with a high concentration of
the nuclease (see: Materials and methods) had no effect on
the formation of 2V,5V-oligoadenylates in any of the preincu-
bation time periods studied. The micrococcal nuclease also
remained active in the preincubated extracts as proven by a
characteristic increase in A260 of the added DNA (not
shown). Moreover, the results show a high stability of the
2–5A synthetase in the pretreatment conditions (Table 1).
Fig. 1. Formation of the 2–5A reaction products by poly(I)poly(C)mem-
brane-bound and Hybond N + membrane-bound material from G. cydonium
extracts. The membrane-bound material was subjected to activity assay as
described in Materials and methods. The products formed from 1 mM ATP
during a 4-h synthesis were dephosphorylated and analyzed by HPLC. The
peaks were identified on the basis of the retention times measured for
authentic compounds and the products were quantified by relative peak
areas. (A) Retention time: adenosine (peak 1)—6.9 min, (2–5) A2 (peak
2)—11.6 min, (2–5) A3 (peak 3)—15.5 min, (2–5) A4 (peak 4)—17.6 min,
(2–5) A5 (peak 5)—18.9 min, (2–5) A6 (peak 6)—20.8 min. (B) Amounts
of products (meanF SE; n= 3) by using the Hybond N + membrane (peaks
1,2 and 3) or poly(I)poly(C)membrane (peaks 1V, 2V and 3V).
Table 1
The effect of the nuclease treatment of G. cydonium extract on the
formation of 2V,5V-linked oligomers from ATP
Preincubation Micrococcal Products (nmol/assay)
time (h) nuclease
p3A2 p3A3 p3A4
0  5.9F 0.3a 1.3F 0.09 0.22F 0.02
+ 5.6F 0.5 1.2F 0.10 0.25F 0.02
1  6.3F 0.4 1.4F 0.08 0.28F 0.02
+ 6.3F 0.3 1.6F 0.07 0.34F 0.01
3  6.0F 0.5 1.5F 0.10 0.33F 0.03
+ 6.4F 0.6 1.8F 0.10 0.46F 0.03
22  5.6F 0.4 1.1F 0.06 0.19F 0.01
+ 6.0F 0.4 1.3F 0.08 0.25F 0.02
The sponge extracts were incubated in the presence or absence of 0.05 U/Al
of the micrococcal nuclease for indicated periods of time and the Hybond
N + -bound material was subjected to activity assay as described in
Materials and methods. The triphosphorylated products, formed from 1
mM ATP during a 2-h synthesis, were analyzed by the HPLC method.
a The data represent meanF SE (n= 3).
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Thus, the degradation of nucleic acids in crude extracts
did not influence the activity of the 2–5A synthetase from
the sponge G. cydonium.
In order to rule out the fact that the binding to the
Hybond N + membrane could cause the possible structural
changes leading to the activation of the enzyme, the assay
was carried out ‘‘in solution.’’ For that, the crude extracts
were incubated overnight in the presence or absence of the
micrococcal nuclease and then used for the determination of
2–5A synthetase activity either in the presence or absence
of poly (I)poly(C). The results in Table 2 reveal that in all
cases, the synthesis of 2–5A oligomers remained the same.
3.3. Comparative studies in a dsRNA-dependent
mammalian cell model system
The effect of the micrococcal nuclease on the poly
(I)poly(C)-activated formation of 2V,5V-linked oligoadeny-
lates was studied in a mammalian cell model. For this
purpose, the extracts of g-IFN-induced PC12 cells were used.
When these extracts were applied to the Hybond N + mem-
brane and the membrane-bound enzymewas used to carry out
the 2–5A synthesis, no products were formed (Fig. 2A). The
presence of 10 Ag/ml of poly(I)poly(C) in the reaction
mixture was sufficient to activate the Hybond N + -bound
enzyme from PC12 cells (Fig. 2B). The formation of 2–5A
oligomers, mainly trimers and tetramers, was even more
elevated in the presence of 100 Ag/ml of poly(I)poly(C)
(Fig. 2C). On the contrary, no synthesis of 2–5A oligomers
was observed when the reaction mixture containing dsRNA
was treated for 30 min with the micrococcal nuclease and
Table 2
The effect of poly(I)poly(C) on the formation of 2V,5V-linked oligomers by
the 2–5A synthetase from nuclease-treated G. cydonium extract
Micrococcal Poly(I)poly(C) Products (nmol/assay)
nuclease (100 Ag/ml)
p3A2 p3A3 p3A4
  7.0F 0.4a 1.1F 0.06 0.25F 0.02
 + 7.1F 0.3 1.0F 0.04 0.26F 0.03
+  7.2F 0.2 1.1F 0.03 0.25F 0.01
+ + 6.9F 0.4 1.0F 0.05 0.22F 0.03
The sponge extracts were incubated overnight in the presence or absence of
0.05 U/Al of the micrococcal nuclease, thereafter the extract was used to
carry out the synthesis of 2–5A oligomers ‘‘in solution’’ as described in
Materials and methods. The triphosphorylated products, formed from 1 mM
ATP during a 2-h synthesis, were analyzed by the HPLC method.
a The data represent meanF SE (n= 3).
Fig. 2. The effect of the micrococcal nuclease on the poly(I)poly(C)-
induced formation of 2–5A oligomers by the 2–5A synthetase from IFN-
induced PC12 cells. The Hybond N + -bound enzyme from PC12 cell
extracts was subjected to activity assay as described in Materials and
methods. The HPLC profile of the products formed from 1 mM ATP during
a 2-h synthesis in the absence of poly(I)poly(C) (A), in the presence of 10
and 100 Ag/ml of poly(I)poly(C), (B) and (C), respectively, or in the
presence of 100 Ag/ml poly(I)poly(C) pretreated for 30 min with 0.05 U/Al
of the micrococcal nuclease (D). Peaks 1, 2, 3 and 4 correspond to ATP,
p3A2, p3A3 and p3A4, respectively.
Fig. 3. The micrococcal nuclease treatment of the membrane-bound
mammalian enzyme–poly(I)poly(C) complex and the membrane-bound
material from G. cydonium extract. The 2–5A synthetase from IFN-
induced PC12 cells or G. cydonium was bound to the Hybond N +
membrane followed by the binding of poly(I)poly(C) (omitted in the case
of sponge extracts), the nuclease treatment of the membrane and activity
assay as described in Materials and methods. The HPLC profile of the
products formed from 1 mM ATP during a 2-h synthesis by the mammalian
(A, C) or during a 0.5-h synthesis by the sponge 2–5A synthetase (B, D)
when the membrane-bound material was treated for 30 min in the absence
(A, B) or presence (C, D) of 0.05 U/Al of the micrococcal nuclease. Peaks 1,
2, 3 and 4 correspond to ATP, p3A2, p3A3 and p3A4, respectively.
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subsequently applied to the membrane-bound enzyme (Fig.
2D). Alternatively, the poly(I)poly(C)membrane was incu-
bated in the presence of the micrococcal nuclease before
binding the 2–5A synthetase to it. Under these conditions,
the nuclease treatment also abolished the synthesis of 2–5A
oligomers (not shown). These results demonstrate that 0.05
U/Al of the micrococcal nuclease was effective enough for
degrading poly(I)poly(C) required for the enzyme activity in
mammalian PC12 cells.
Further, the effect of the nuclease on the synthesis of 2–
5A was studied after binding the 2–5A synthetase to
poly(I)poly(C), i.e. after the formation of the enzyme–
dsRNA complex. For that, the enzyme from the PC12 cells
was bound to the Hybond N + membrane followed by the
binding of poly(I)poly(C). The micrococcal nuclease treat-
ment of such a membrane abolished the synthesis of the
products (Fig. 3A and C). The same result was obtained
using the poly(I)poly(C)membrane-bound enzyme from
PC12 cells. In contrast, when the Hybond N + -bound
material from G. cydonium extracts was used in the assay,
the nuclease treatment had no effect on the synthesis of 2–
5A products (Fig. 3B and D).
3.4. A biochemical characterization of the 2–5A oligomer
formation by the 2–5A synthetase from G. cydonium
On the basis of our finding that the formation of 2–5A
oligomers by the sponge 2–5A synthetase was poly
(I)poly(C)-independent, all subsequent experiments were
performed using the Hybond N + -bound enzyme without an
additional dsRNA. The requirement for divalent cations, an
optimal temperature and the pH value were determined to
optimize the rate of formation of 2–5A oligoadenylates.
Fig. 4A demonstrates the yields of ATP oligomerization
at different temperatures. It can be seen that the enzyme is
active in quite a wide range of temperatures used (10–70
jC). The formation of 2–5A oligomers was most effective
in the temperature range of 25–45 jC with an optimum at
about 37 jC.
Fig. 4B demonstrates the dependence of the formation of
2–5A oligomers on pH of the assay buffer. It appears that
for the maximal activity, basic pHs with an optimum at
about 8 are needed. The quantities of 2–5A oligomers
formed at different concentrations of MgCl2 are presented
in Fig. 4C. The results show that the maximal rate of
Fig. 4. Biochemical characteristics of the formation of 2–5A oligomers by the Hybond N + -bound enzyme from G. cydonium extracts. (A) Temperature-
dependence. After the incubation of 1 mM ATP+[14C]ATP with membrane-bound enzyme for 4 h, the reaction products were separated by TLC on PEI-
cellulose as described in Materials and methods. The quantification of the products on the autoradiograms was performed by the relative spot intensities. Each
point represents a meanF SE (n= 4). (B) pH-dependence. After the incubation of 1 mM ATP with membrane-bound enzyme for 0.5 h at an indicated pH of the
reaction mixture, the triphosphorylated products were analyzed by HPLC as described in Materials and methods. Each point represents a mean of the two
independent experiments. (C) The effect of MgCl2. The products formed from 1 mM ATP at an increasing concentration of MgCl2 during a 4-h synthesis were
dephosphorylated and analyzed by the HPLC method. The values represent means of the two independent experiments. (D) The time-course of formation of 2–
5A oligomers. ATP (0.63 mM) was incubated with membrane-bound enzyme for indicated periods of time and the triphosphorylated products were analyzed by
HPLC and quantified as described in Materials and methods.
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formation of the products from 1 mM ATP was observed at
5 mM MgCl2, while no activity of the enzyme was detected
in the absence of MgCl2 (Fig. 4C). In a separate series of
experiments, we studied the ability of different divalent
metal ions (Mn2 + , Zn2 + , Ca2 + ) to substitute Mg2 + in
the oligomerization reaction of ATP. The results show that
the potency of different divalent ions to activate the sponge
synthetase decreased in the following order: Mg >Mn>Zn
resulting under these conditions in the conversion of 96%,
85% and 38% of ATP, respectively (Fig. 5A–C). The
products were not formed in the presence of CaCl2 (Fig.
5D).
Mammalian 2–5A synthetases have a characteristic pat-
tern of 2–5A oligomers synthesized by each protein [9,10].
Looking at the pattern of the oligomers formed by the
sponge synthetase, we found a higher proportion of the
2–5A dimer compared to that of the longer products (Fig.
5A). Fig. 4D shows the time-course of formation of 2V,5V-
linked di-, tri-, tetra-, and penta-adenylates from ATP. It
demonstrates that the disappearance of ATP was quantita-
tively related to the appearance of oligonucleotides. During
the first stage of the reaction, when up to 50% of ATP was
used, the dinucleotide was prevalent but the ratio of dimer to
longer oligomers decreased over time. Nevertheless, the
molar ratio of dimer to total products was about 0.5 when
approximately 90% of ATP was converted to its products
(Fig. 4D).
4. Discussion
Mammalian 2–5A synthetases were discovered as IFN-
induced and dsRNA-activated enzymes (reviewed in Ref.
[30]). Their dependence on dsRNAwas proven by means of
the enzymes purified from cell extracts [31–33] and, later
by means of recombinant proteins [34–37]. In our earlier
study, we discovered that the enzyme from the crude extract
of a lower invertebrate, the marine sponge G. cydonium,
also has a high 2–5A synthetase activity when immobilized
to the poly(I)poly(C)membrane [18]. Some years ago, we
succeeded in cloning the putative 2–5A synthetase from the
sponge G. cydonium, which shows some, although limited,
homology to small 2–5A synthetase isoforms of mouse,
chicken and human [20]. However, up to now, the expres-
sion of this cDNA clone in neither the bacterial nor insect
cells has resulted in the active protein (Kuusksalu, A.,
unpublished data). It is not clear whether the polypeptide
obtained is responsible for the observed 2–5A synthetase
activity in G. cydonium. Therefore, to further study the
parameters needed for the 2–5A synthetase activity in the
sponge, we used the membrane-bound enzyme preparations
from the crude extracts of G. cydonium in the present study.
We found that the Hybond N + membrane as well as other
membranes (Hybond C, Hybond N, PVDF) are capable of
binding the 2–5A synthetase from the crude extracts of G.
cydonium nonspecifically and this membrane can be used to
carry out the synthesis of 2–5A without an additional
dsRNA (Fig. 1). The 2–5A synthetase from IFN-induced
PC12 cells, used by us as a mammalian cell model, is also
capable of nonspecific binding to Hybond N + , but no
activity of the enzyme is observed in the absence of dsRNA.
As expected, the 2–5A synthesis can be induced in this case
in a dose-dependent manner by adding poly(I)poly(C) as a
dsRNA cofactor to the reaction mixture (Fig. 2A–C).
Provided that the sponge 2–5A synthetase behaves like
mammalian enzymes, it is conceivable that the crude extract
of G. cydonium contains dsRNA activators which bind
together with the protein to the membrane and activate the
2–5A synthetase. To exclude this possibility, the sponge
extracts were treated with the micrococcal nuclease, an
enzyme used to hydrolyse single-stranded and double-
stranded nucleic acids in crude cell-free extracts [38,39].
Our results in Table 1 reveal that the incubation of the
extracts with the nuclease for prolonged periods of time (up
to overnight) did not influence the activity of the sponge 2–
5A synthetase. On the contrary, the same concentration of
the micrococcal nuclease was, within 30 min of incubation,
effective in degrading poly(I)poly(C) required for the
enzyme activity in PC12 cells (Fig. 2C and D). In another
series of experiments with IFN-induced PC12 cells, we
studied the effect of the nuclease on poly(I)poly(C) in the
presence of the protein bound to it. We showed that the
nuclease treatment of the 2–5A synthetase–poly(I)poly(C)
complex also abolished the synthesis of 2–5A oligomers
(Fig. 3A and C). Once again, the membrane-bound 2–5A
Fig. 5. The effect of different divalent metal ions on the formation of
products by the 2–5A synthetase from G. cydonium. The HPLC profile of
the products formed from 1 mM ATP during a 3-h synthesis in the presence
of 5 mM MgCl2 (A), 5 mM MnCl2 (B), 5 mM Zn-acetate (C) or 5 mM
CaCl2 (D) in the reaction mixture, pH 7.6. Peaks 1, 2, 3 and 4 correspond to
ATP, p3A2, p3A3 and p3A4, respectively. The group of peaks, designated as
‘‘5,’’ contains p3A5 and oligomers of longer chain length.
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synthetase from the sponge exhibited similar activity, irre-
spective of whether it had been subjected to the nuclease
treatment (Fig. 3B and D).
To ensure that binding of the sponge 2–5A synthetase to
the membrane would not bring about any structural mod-
ifications of the enzyme affecting its activation process, the
formation of 2–5A oligomers was measured also ‘‘in
solution.’’ The data in Table 2 show that the 2–5A synthe-
tase activity was the same independent of the micrococcal
nuclease treatment and the presence or absence of poly
(I)poly(C) in the reaction mixture. These data together with
the abovementioned results suggest that the 2–5A synthe-
tase from G. cydonium, differently from mammalian 2–5A
synthetases, does not need dsRNA for its activity.
The exact nature of interaction of an RNA activator with
an RNA-binding domain in the proteins of the 2–5A
synthetase family is not known [10,40]. Moreover, none
of the proteins of this family isolated so far possesses a
typical RNA-binding domain which is characteristic of
many dsRNA-binding proteins (reviewed in Ref. [13]).
The 2–5A oligoadenylate synthetase, which has previously
been believed to be activated only by dsRNA, can also be
activated by RNA ligands with a little secondary structure
[40]. Concerning natural activators of the enzyme, certain
small viral RNAs have been shown to act as activators upon
viral infection [41,42]. At the same time, little is known
about cellular activators of 2–5A synthetases in virus-non-
infected cells. With regard to the latter, the activation of the
2–5A synthetase by certain nuclear dsRNAs (HnRNA) has
been proposed [43,44]. The only report that relates to the
naturally occurring, non-dsRNA cellular activators of the
enzyme demonstrates that high concentrations of fructose-
1,6-biphosphate can activate the 2–5A synthetase [39].
There are several possibilities to explain our results. The
corresponding sponge protein may be active per se or in the
form of a hypothetical strong protein–nucleic acid complex
which is resistant to the action of nucleases. Alternatively, it
may be activated by a yet unknown component present in
the sponge extract. Further experiments will be required to
elucidate possible activators (if any) of the sponge 2–5A
synthetase.
The optimization studies of the synthesis of 2–5A
oligomers revealed that basic pH values with an optimum
of 8.0, the presence of MgCl2 in excess with respect to
ATP and the temperature optimum of 37 jC are necessary
for the maximal rate of formation of products by the
sponge 2–5A synthetase (Fig. 4A–C). It has been estab-
lished that mammalian 2–5A synthetases belong to the
class of nucleotidyltransferases which require divalent
metal ions for their activity [45]. The presence of Mg2 +
has been shown to be obligatory for the activity of
mammalian 2–5A synthetases [29]. Our results confirm
that it is also valid for the sponge synthetase. Other
divalent cations (Mn2 + , Zn2 + ), which may be chelated
by carboxylate residues in the catalytic center of nucleo-
tidyltransferases [46], were able to substitute Mg2 + with a
lower efficiency (Fig. 5). Several metal ions (copper, ion,
zinc) have been shown to be strongly inhibitory to the
small and medium human 2–5A synthetases [47]. The
effects of divalent cations on the activity of the sponge 2–
5A synthetase deserve further investigation, since we
observed a better formation of 2–5A oligomers in the
presence of zinc than in the presence of calcium.
We have previously shown by the MALDI-MS analysis
that the 2–5A synthetase from G. cydonium is capable of
synthesizing oligoadenylates from dimers to octamers [19].
The kinetic studies of formation of different oligomers show
that the 2–5A dimer is the first product to accumulate in a
predominant proportion during the first stage of the reaction.
At a higher conversion percentage of ATP, the yields of the
trimer and other longer oligomers gradually increase (Fig.
4D). However, the molar concentrations of oligomers higher
than a pentamer remain low.
The mammalian 2–5A synthetases are characterized by
different oligomer patterns and kinetic parameters of for-
mation of 2–5A oligomers [9,10]. The kinetics of formation
of the products by the sponge synthetase (Fig. 4D) is similar
to that observed by Justesen et al. [48] who carried out
kinetic studies with the 2–5A synthetase purified from a
rabbit reticulocyte lysate. When 90% of ATP was converted
to its products, we found the calculated molar ratio of dimer
to total products to be about 0.5 vs. 0.41 calculated in
experiments with the enzyme from rabbit reticulocytes [48].
The high ratio of dimer to total products is also typical of a
large human isozyme p100 [49], whereas the medium
isozyme p69 is quite different. Hovanessian et al. [50] have
shown that at a maximum activity of each enzyme, the ratio
of dimer to other oligoadenylates is 0.49 and 0.08 for the
large human 2–5A synthetase isozyme p100 and medium
isozyme p69, respectively. Taken together, our enzymatic
studies demonstrate that the 2–5A synthetase from the
sponge G. cydonium behaves like a specific isoform of
enzymes of the 2–5A synthetase family in the absence of
dsRNA.
The cellular abundance of specific 2–5A synthetase
isoforms and their localization in different subcellular com-
partments may refer to the multiplicity of functions they
exert in cells [51–53]. Although the general scheme for the
functioning of the 2–5A synthetase/RNase L system is well
established, other mechanisms of actions of specific iso-
zymes in mammalian cells cannot be ruled out. Lately, it has
been demonstrated that besides its oligoadenylate synthesiz-
ing activity, the murine 2–5A synthetase isoform 9–2
functions as a proapoptotic protein of the Bcl-2 family in
an RNase L-independent way [53]. Since 2V,5V-diadenylates
have a low affinity to bind and thus activate the RNase L
[49], it has been proposed that they have an independent
antiviral activity or some other cellular effects [9,37,54].
Also, the potential role of the large human isozyme p100 in
pre-RNA splicing through generating the 2V,5V-phosho-
diester bond in the intermediate lariat structure has been
proposed [55].
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At present, we do not know the role of 2–5A synthesis in
the sponges. By now, the 2–5A synthetase as a single
component of the whole mammalian 2–5A system has been
identified in sponges. Whether an interferon-like antimicro-
bial system exists in sponges is a matter of future studies.
Thus, the specific need for 2–5A products as extracellular
or intracellular signalling molecules for sponges has to be
established.
The results of the present study give evidence of the
dsRNA-independent synthesis of 2–5A oligomers. The
preferential synthesis of dimeric 2–5A molecules refers to
the mode of action of the oligoadenylates formed which
may not involve the RNase L pathway.
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